LifeMD is trading at $3.45 (down 5.22%) amid broader healthcare sector softness and a general risk-off trading environment.
- No company-specific news or catalysts have been identified to explain the downward move.
- The decline is consistent with recent volatility and appears driven by market sentiment rather than fundamental events.
- The stock remains under pressure following a weak morning move without significant buy-side support.